Click for best price
Migraine Drugs Market Size, Share 2022
Market Analysis and Insights: Global Migraine Drugs Market
The global Migraine Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Migraine Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Migraine Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Migraine Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Migraine Drugs market.
Global Migraine Drugs Scope and Market Size
Migraine Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Migraine Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Sumatriptan
Zolmitriptan
Rizatriptan
Others Drug
Segment by Application
Hospitals
Clinics
Household Use
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Migraine Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Migraine Drugs, with price, sales, revenue, and global market share of Migraine Drugs from 2019 to 2022.
Chapter 3, the Migraine Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Migraine Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Migraine Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Migraine Drugs.
Chapter 13, 14, and 15, to describe Migraine Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Migraine Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Migraine Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Migraine Drugs Product Introduction
1.2 Global Migraine Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Migraine Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Migraine Drugs Sales in Volume for the Year 2017-2028
1.3 United States Migraine Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Migraine Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Migraine Drugs Sales in Volume for the Year 2017-2028
1.4 Migraine Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Migraine Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Migraine Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Migraine Drugs Market Dynamics
1.5.1 Migraine Drugs Industry Trends
1.5.2 Migraine Drugs Market Drivers
1.5.3 Migraine Drugs Market Challenges
1.5.4 Migraine Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Migraine Drugs Market Segment by Type
2.1.1 Sumatriptan
2.1.2 Zolmitriptan
2.1.3 Rizatriptan
2.1.4 Others Drug
2.2 Global Migraine Drugs Market Size by Type
2.2.1 Global Migraine Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Migraine Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Migraine Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Migraine Drugs Market Size by Type
2.3.1 United States Migraine Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Migraine Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Migraine Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Migraine Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Household Use
3.1.4 Others
3.2 Global Migraine Drugs Market Size by Application
3.2.1 Global Migraine Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Migraine Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Migraine Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Migraine Drugs Market Size by Application
3.3.1 United States Migraine Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Migraine Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Migraine Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Migraine Drugs Competitor Landscape by Company
4.1 Global Migraine Drugs Market Size by Company
4.1.1 Top Global Migraine Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Migraine Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Migraine Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Migraine Drugs Price by Manufacturer (2017-2022)
4.2 Global Migraine Drugs Concentration Ratio (CR)
4.2.1 Migraine Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Migraine Drugs in 2021
4.2.3 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Migraine Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Migraine Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Migraine Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Migraine Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Migraine Drugs Market Size by Company
4.5.1 Top Migraine Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Migraine Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Migraine Drugs Sales by Players (2020, 2021 & 2022)
5 Global Migraine Drugs Market Size by Region
5.1 Global Migraine Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Migraine Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Migraine Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Migraine Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Migraine Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Migraine Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Migraine Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Migraine Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Migraine Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Migraine Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Migraine Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Migraine Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Migraine Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Migraine Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Corporation Information
7.1.2 Allergan Description and Business Overview
7.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Allergan Migraine Drugs Products Offered
7.1.5 Allergan Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Migraine Drugs Products Offered
7.2.5 Merck Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Migraine Drugs Products Offered
7.3.5 Pfizer Recent Development
7.4 Teva
7.4.1 Teva Corporation Information
7.4.2 Teva Description and Business Overview
7.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Teva Migraine Drugs Products Offered
7.4.5 Teva Recent Development
7.5 Pfizer
7.5.1 Pfizer Corporation Information
7.5.2 Pfizer Description and Business Overview
7.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Pfizer Migraine Drugs Products Offered
7.5.5 Pfizer Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporation Information
7.6.2 Johnson & Johnson Description and Business Overview
7.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Johnson & Johnson Migraine Drugs Products Offered
7.6.5 Johnson & Johnson Recent Development
7.7 Endo International
7.7.1 Endo International Corporation Information
7.7.2 Endo International Description and Business Overview
7.7.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Endo International Migraine Drugs Products Offered
7.7.5 Endo International Recent Development
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporation Information
7.8.2 GlaxoSmithKline Description and Business Overview
7.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 GlaxoSmithKline Migraine Drugs Products Offered
7.8.5 GlaxoSmithKline Recent Development
7.9 Impax
7.9.1 Impax Corporation Information
7.9.2 Impax Description and Business Overview
7.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Impax Migraine Drugs Products Offered
7.9.5 Impax Recent Development
7.10 Abbott
7.10.1 Abbott Corporation Information
7.10.2 Abbott Description and Business Overview
7.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Abbott Migraine Drugs Products Offered
7.10.5 Abbott Recent Development
7.11 Bayer
7.11.1 Bayer Corporation Information
7.11.2 Bayer Description and Business Overview
7.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Bayer Migraine Drugs Products Offered
7.11.5 Bayer Recent Development
7.12 Eli Lilly
7.12.1 Eli Lilly Corporation Information
7.12.2 Eli Lilly Description and Business Overview
7.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Eli Lilly Products Offered
7.12.5 Eli Lilly Recent Development
7.13 Ethypharm
7.13.1 Ethypharm Corporation Information
7.13.2 Ethypharm Description and Business Overview
7.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Ethypharm Products Offered
7.13.5 Ethypharm Recent Development
7.14 Kowa Pharmaceuticals America
7.14.1 Kowa Pharmaceuticals America Corporation Information
7.14.2 Kowa Pharmaceuticals America Description and Business Overview
7.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Kowa Pharmaceuticals America Products Offered
7.14.5 Kowa Pharmaceuticals America Recent Development
7.15 Winston Pharmaceuticals
7.15.1 Winston Pharmaceuticals Corporation Information
7.15.2 Winston Pharmaceuticals Description and Business Overview
7.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Winston Pharmaceuticals Products Offered
7.15.5 Winston Pharmaceuticals Recent Development
7.16 AstraZeneca
7.16.1 AstraZeneca Corporation Information
7.16.2 AstraZeneca Description and Business Overview
7.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 AstraZeneca Products Offered
7.16.5 AstraZeneca Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Migraine Drugs Industry Chain Analysis
8.2 Migraine Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Migraine Drugs Distributors
8.3 Migraine Drugs Production Mode & Process
8.4 Migraine Drugs Sales and Marketing
8.4.1 Migraine Drugs Sales Channels
8.4.2 Migraine Drugs Distributors
8.5 Migraine Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Migraine Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Migraine Drugs Market Trends
Table 3. Migraine Drugs Market Drivers
Table 4. Migraine Drugs Market Challenges
Table 5. Migraine Drugs Market Restraints
Table 6. Global Migraine Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Migraine Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Migraine Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Migraine Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Migraine Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Migraine Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Migraine Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Migraine Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Migraine Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Migraine Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Drugs as of 2021)
Table 18. Top Players of Migraine Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Migraine Drugs Product Type
Table 20. Date of International Manufacturers Enter into Migraine Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Migraine Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Migraine Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Migraine Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Migraine Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Migraine Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Migraine Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Migraine Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Migraine Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Migraine Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Migraine Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Migraine Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Migraine Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Allergan Corporation Information
Table 43. Allergan Description and Business Overview
Table 44. Allergan Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Allergan Migraine Drugs Product
Table 46. Allergan Recent Development
Table 47. Merck Corporation Information
Table 48. Merck Description and Business Overview
Table 49. Merck Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Merck Product
Table 51. Merck Recent Development
Table 52. Pfizer Corporation Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Pfizer Product
Table 56. Pfizer Recent Development
Table 57. Teva Corporation Information
Table 58. Teva Description and Business Overview
Table 59. Teva Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Teva Product
Table 61. Teva Recent Development
Table 62. Pfizer Corporation Information
Table 63. Pfizer Description and Business Overview
Table 64. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Pfizer Product
Table 66. Pfizer Recent Development
Table 67. Johnson & Johnson Corporation Information
Table 68. Johnson & Johnson Description and Business Overview
Table 69. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Johnson & Johnson Product
Table 71. Johnson & Johnson Recent Development
Table 72. Endo International Corporation Information
Table 73. Endo International Description and Business Overview
Table 74. Endo International Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Endo International Product
Table 76. Endo International Recent Development
Table 77. GlaxoSmithKline Corporation Information
Table 78. GlaxoSmithKline Description and Business Overview
Table 79. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Recent Development
Table 82. Impax Corporation Information
Table 83. Impax Description and Business Overview
Table 84. Impax Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Impax Product
Table 86. Impax Recent Development
Table 87. Abbott Corporation Information
Table 88. Abbott Description and Business Overview
Table 89. Abbott Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Abbott Product
Table 91. Abbott Recent Development
Table 92. Bayer Corporation Information
Table 93. Bayer Description and Business Overview
Table 94. Bayer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Bayer Product
Table 96. Bayer Recent Development
Table 97. Eli Lilly Corporation Information
Table 98. Eli Lilly Description and Business Overview
Table 99. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Eli Lilly Product
Table 101. Eli Lilly Recent Development
Table 102. Ethypharm Corporation Information
Table 103. Ethypharm Description and Business Overview
Table 104. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Ethypharm Product
Table 106. Ethypharm Recent Development
Table 107. Kowa Pharmaceuticals America Corporation Information
Table 108. Kowa Pharmaceuticals America Description and Business Overview
Table 109. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Kowa Pharmaceuticals America Product
Table 111. Kowa Pharmaceuticals America Recent Development
Table 112. Winston Pharmaceuticals Corporation Information
Table 113. Winston Pharmaceuticals Description and Business Overview
Table 114. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Winston Pharmaceuticals Product
Table 116. Winston Pharmaceuticals Recent Development
Table 117. AstraZeneca Corporation Information
Table 118. AstraZeneca Description and Business Overview
Table 119. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. AstraZeneca Product
Table 121. AstraZeneca Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Migraine Drugs Customers List
Table 125. Migraine Drugs Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Migraine Drugs Product Picture
Figure 2. Global Migraine Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Migraine Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Migraine Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Migraine Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Migraine Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Migraine Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Migraine Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Migraine Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Migraine Drugs Report Years Considered
Figure 11. Product Picture of Sumatriptan
Figure 12. Product Picture of Zolmitriptan
Figure 13. Product Picture of Rizatriptan
Figure 14. Product Picture of Others Drug
Figure 15. Global Migraine Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Migraine Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Migraine Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Migraine Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 19. Global Migraine Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Migraine Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 21. United States Migraine Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Migraine Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Migraine Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Migraine Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 25. United States Migraine Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Migraine Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 27. Product Picture of Hospitals
Figure 28. Product Picture of Clinics
Figure 29. Product Picture of Household Use
Figure 30. Product Picture of Others
Figure 31. Global Migraine Drugs Market Share by Application in 2022 & 2028
Figure 32. Global Migraine Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Migraine Drugs Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Migraine Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 35. Global Migraine Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Migraine Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 37. United States Migraine Drugs Market Share by Application in 2022 & 2028
Figure 38. United States Migraine Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Migraine Drugs Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Migraine Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 41. United States Migraine Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Migraine Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 44. North America Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. Europe Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 55. Asia-Pacific Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 67. Latin America Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 72. Middle East & Africa Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. U.A.E Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Migraine Drugs Value Chain
Figure 77. Migraine Drugs Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
